{"product_id":"ucsf-addiction-conference-2025","title":"UCSF Addiction Conference 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: addiction therapist\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe 5th Annual UCSF Addiction CME Conference aims to increase the core competency of medical teams in the inpatient and outpatient settings to improve care for patients who use drugs and alcohol. This conference will increase skills in diagnosis, assessment, and treatment of common substance use disorders through didactics taught by local addiction experts, as well as small group discussions to apply this knowledge to patient care. This is a Virtual Conference.\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003ePhysicians\u003c\/p\u003e\n\u003cp\u003eNurse practitioners and Physician Associates (PAs)\u003c\/p\u003e\n\u003cp\u003eTopics Covered\u003c\/p\u003e\n\u003cp\u003eKeynote address from a person with lived experience of Substance Use Disorder (SUD)\u003c\/p\u003e\n\u003cp\u003eSUD as a brain disease, stigma\u003c\/p\u003e\n\u003cp\u003eOpioid Use Disorder, including starting buprenorphine and methadone\u003c\/p\u003e\n\u003cp\u003eAlcohol use disorder\u003c\/p\u003e\n\u003cp\u003eBenzodiazepine use disorder and withdrawal management\u003c\/p\u003e\n\u003cp\u003eStimulant use disorder\u003c\/p\u003e\n\u003cp\u003ePregnancy and SUDs\u003c\/p\u003e\n\u003cp\u003ePain and SUDs\u003c\/p\u003e\n\u003cp\u003eHospital based care for patients with SUDs\u003c\/p\u003e\n\u003cp\u003eCommunication and documentation in caring for patients with SUDs\u003c\/p\u003e\n\u003cp\u003eObjectives\u003c\/p\u003e\n\u003ch3\u003eAttendees completing this course will be able to:\u003c\/h3\u003e\n\u003cp\u003eApply new knowledge in practice to more often recognize signs of substance use disorders (SUDs)\u003c\/p\u003e\n\u003cp\u003eImplement screening in practice to confirm SU\u003c\/p\u003e\n\u003cp\u003eConsider a broader set and combination of evidence-based treatments for opioid, alcohol, and stimulant use disorders in management of SU\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003c\/p\u003e\n\u003cp\u003e10_Dianna Coffa – Communication with Patients.pdf\u003c\/p\u003e\n\u003cp\u003e11_Tauheed Zaman – Benzodiazepine.pdf\u003c\/p\u003e\n\u003cp\u003e12_Alex Logan – Hospital Based Care.pdf\u003c\/p\u003e\n\u003cp\u003e13_Hannah Snyder – Telehealth and Patient Centered Documentation.pdf\u003c\/p\u003e\n\u003cp\u003e14 _Case 2- AUD, Stim UD, Benzo UD_PARTICIPANT.docx\u003c\/p\u003e\n\u003cp\u003e16_Mishka Terplan – Pregnancy and SUD.pdf\u003c\/p\u003e\n\u003cp\u003e17_Elizabeth Abbs – Controlled Medication Management.pdf\u003c\/p\u003e\n\u003cp\u003e2_Johanna Sluser – Stigma and Clinical Diagnosis of SUD.pdf\u003c\/p\u003e\n\u003cp\u003e3_VERSION 2_Khaled Moussawi_SUD as a Brain Disease.pdf\u003c\/p\u003e\n\u003cp\u003e4 _Andy Tompkins – OUD Diagnosis and Methadone Induction.pdf\u003c\/p\u003e\n\u003cp\u003e5_Christy Soran – Complex Buprenorphine Inductions.pdf\u003c\/p\u003e\n\u003cp\u003e6_Case 1- OUD_PARTICIPANT.docx\u003c\/p\u003e\n\u003cp\u003e8_ Ayesha Appa – Stimulant Use Disorder Treatment.pdf\u003c\/p\u003e\n\u003cp\u003e9_ Triveni Defries – Alcohol Use Disorder.pdf\u003c\/p\u003e\n\u003cp\u003eApril 17 AM.mp4\u003c\/p\u003e\n\u003cp\u003eApril 17 PM.mp4\u003c\/p\u003e\n\u003cp\u003eApril 18 AM.mp4\u003c\/p\u003e\n\u003cp\u003eApril 18 PM.mp4\u003c\/p\u003e\n\u003cp\u003eSyllabus Introduction_MDM25P05.pdf\u003c\/p\u003e\n\u003ch3\u003e* Detail:\u003c\/h3\u003e\n\u003cp\u003eDay 1: April 17, 2025\u003c\/p\u003e\n\u003cp\u003eWelcome from the Conference Co-Chairs: Jesse Ristau*, MD and Alex Logan*, MD\u003c\/p\u003e\n\u003cp\u003eJose P, Drug and Alcohol Counselor\u003c\/p\u003e\n\u003cp\u003eDrug Treatment Program\u003c\/p\u003e\n\u003cp\u003eKeynote Address\u003c\/p\u003e\n\u003cp\u003eJohanna Sluser*, FNP-C, CARN-AP\u003c\/p\u003e\n\u003cp\u003eHospital medicine, Psychiatry\u003c\/p\u003e\n\u003cp\u003eStigma and clinical diagnosis of SUD\u003c\/p\u003e\n\u003cp\u003eKhaled Moussawi, MD, PhD – University of California San Francisco\u003c\/p\u003e\n\u003cp\u003eNeurology\u003c\/p\u003e\n\u003cp\u003eSUD as a brain disease\u003c\/p\u003e\n\u003cp\u003eBreak – 15 mins\u003c\/p\u003e\n\u003cp\u003eAndy Tompkins*, MD\u003c\/p\u003e\n\u003cp\u003ePsychiatry, OTP\u003c\/p\u003e\n\u003cp\u003eOUD diagnosis and methadone induction\u003c\/p\u003e\n\u003cp\u003eChristy Soran*, MD, MPH\u003c\/p\u003e\n\u003cp\u003ePrimary Care, OBIC\u003c\/p\u003e\n\u003cp\u003eComplex Buprenorphine Inductions\u003c\/p\u003e\n\u003cp\u003eSmall Groups\u003c\/p\u003e\n\u003cp\u003eCase 1: OUD diagnosis and treatment\u003c\/p\u003e\n\u003cp\u003eJesse Ristau*, MD\u003c\/p\u003e\n\u003cp\u003ePrimary Care, Inpatient Consult\u003c\/p\u003e\n\u003cp\u003eBreak – 15 mins\u003c\/p\u003e\n\u003cp\u003eAyesha Appa*, MD\u003c\/p\u003e\n\u003cp\u003eInternal Medicine\u003c\/p\u003e\n\u003cp\u003eStimulants, drug involved deaths\u003c\/p\u003e\n\u003cp\u003eTriveni Defries*, MD\u003c\/p\u003e\n\u003cp\u003eInternal Medicine\u003c\/p\u003e\n\u003cp\u003eAlcohol Use Disorder: Diagnosis and Treatment\u003c\/p\u003e\n\u003cp\u003eClosing\u003c\/p\u003e\n\u003cp\u003eDay 2: April 18, 2025\u003c\/p\u003e\n\u003cp\u003eIntroductions: Jesse Ristau*, MD and Alex Logan*, MD\u003c\/p\u003e\n\u003cp\u003eDianna Coffa*, MD\u003c\/p\u003e\n\u003cp\u003eFamily \u0026amp; Community Medicine, ZSFG\u003c\/p\u003e\n\u003cp\u003eCommunication with patients who use substances\u003c\/p\u003e\n\u003cp\u003eTauheed Zaman*, MD\u003c\/p\u003e\n\u003cp\u003ePsychiatry, SFVA\u003c\/p\u003e\n\u003cp\u003eBenzodiazepine Use disorder and detoxification\u003c\/p\u003e\n\u003cp\u003eBreak – 15 mins\u003c\/p\u003e\n\u003cp\u003eAlex Logan*, MD\u003c\/p\u003e\n\u003cp\u003eHospital Medicine\u003c\/p\u003e\n\u003cp\u003eHospital based care for patients with SUD including Opioid Withdrawal Management\u003c\/p\u003e\n\u003cp\u003eHannah Snyder*, MD\u003c\/p\u003e\n\u003cp\u003eFamily \u0026amp; Community Medicine, ZSFG\u003c\/p\u003e\n\u003cp\u003eTelehealth and Patient Centered Documentation\u003c\/p\u003e\n\u003cp\u003eSmall Groups\u003c\/p\u003e\n\u003cp\u003eCase 2: Complex care inpt, outpt, multiple substances, utox (includes 5min of transition time)\u003c\/p\u003e\n\u003cp\u003eJessica Ristau*, MD\u003c\/p\u003e\n\u003cp\u003ePrimary care and Inpatient consult\u003c\/p\u003e\n\u003cp\u003eBreak – 15 mins\u003c\/p\u003e\n\u003cp\u003eMishka Terplan*, MD\u003c\/p\u003e\n\u003cp\u003eOB\/GYN\u003c\/p\u003e\n\u003cp\u003ePregnancy and SUD\u003c\/p\u003e\n\u003cp\u003eElizabeth Abbs*, MD\u003c\/p\u003e\n\u003cp\u003eInternal Medicine\u003c\/p\u003e\n\u003cp\u003eControlled medication management and SUD\u003c\/p\u003e\n\u003cp\u003eClosing\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405769232580,"sku":null,"price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/UCSF-Addiction-Conference-2025.jpg?v=1784215897","url":"https:\/\/medicalcoursespro.com\/products\/ucsf-addiction-conference-2025","provider":"Medicalcoursespro","version":"1.0","type":"link"}